Ekso Bionics Inc.

NASDAQ: EKSO · Real-Time Price · USD
3.42
0.07 (2.09%)
At close: Aug 22, 2025, 10:33 AM

Ekso Bionics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.49M 8.64M 20.52M 40.41M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
433K 392K 231K 164K
Receivables
7.24M 5.64M 4.63M 4.66M
Inventory
4.57M 5.05M 5.19M 2.24M
Other Current Assets
541K 875K 700K n/a
Total Current Assets
18.84M 20.21M 31.04M 47.8M
Property-Plant & Equipment
2.37M 3M 3.99M 1.21M
Goodwill & Intangibles
5.01M 5.32M 5.65M n/a
Total Long-Term Assets
7.81M 8.71M 9.87M 1.37M
Total Assets
26.65M 28.92M 40.9M 49.17M
Account Payables
1.55M 1.85M 3.15M 3.11M
Deferred Revenue
1.96M 1.99M 1.12M 1.22M
Short-Term Debt
1.25M 1.25M 2.31M 229K
Other Current Liabilities
2.35M 606K n/a -34K
Total Current Liabilities
7.54M 8.12M 9.2M 6.86M
Long-Term Debt
3.85M 4.83M 3.77M 1.99M
Other Long-Term Liabilities
182K 471K 374K 1.62M
Total Long-Term Liabilities
6.41M 8.2M 6.26M 5.09M
Total Liabilities
13.95M 16.31M 15.46M 11.95M
Total Debt
5.98M 7.17M 7.5M 2.22M
Common Stock
22K 15K 13K 13K
Retained Earnings
-250.47M -239.15M -223.95M -208.87M
Comprehensive Income
957K 156K 563K -17K
Shareholders Equity
12.71M 12.61M 25.44M 37.22M
Total Investments
n/a n/a n/a n/a